THERIVA BIOLOGICS INC (TOVX)

US87164U4094 - Common Stock

0.37  0 (-0.19%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Minority Interest Expense
N/A0.000.0070.00K80.00K
Operating Expenses
21.43M21.38M14.27M10.16M15.66M
Research and Development
14.31M11.72M7.80M5.13M11.08M
Selling, General, and Administrative Expenses
6.42M7.56M6.47M5.03M4.58M
Operating Income
-21.43M-21.38M-14.27M-10.16M-15.66M
Interest Income/Expense
1.44M470.00K10.00K40.00K280.00K
Other Income/Expense
N/AN/AN/AN/A0.00
Non Recurring Items
0.00-200.00KN/AN/AN/A
Income Before Taxes
-19.99M-21.11M-14.27M-10.12M-15.38M
Income Tax
-1.64M-1.43MN/AN/AN/A
Net Income
-18.35M-20.03M-23.19M-12.56M-16.08M
EBITDA
-21.30M-21.29M-14.18M-9.96M-15.42M
 
Per Share Data
EPS Diluted Total Ops
-1.14-1.31-1.90-6.61-9.80
Non GAAP EPS
-1.17-1.27-2.10-6.10-9.30
 
Statistics

All data in USD

Charts